BCM
BML Capital Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.57M | Buy |
3,057,526
+315,209
| +11% | +$678K | 4.97% | 7 |
|
|
2025
Q1 | $12M | Buy |
2,742,317
+474,253
| +21% | +$2.07M | 9.7% | 4 |
|
|
2024
Q4 | $10.6M | Hold |
2,268,064
| – | – | 6.58% | 4 |
|
|
2024
Q3 | $15.9M | Buy |
2,268,064
+302,064
| +15% | +$2.12M | 9.37% | 6 |
|
|
2024
Q2 | $13.5M | Buy |
1,966,000
+1,132,883
| +136% | +$7.77M | 9.62% | 5 |
|
|
2024
Q1 | $11.8M | Sell |
833,117
-3,721,135
| -82% | -$52.6M | 7.77% | 4 |
|
|
2023
Q4 | $3.43M | Buy |
4,554,252
+639,252
| +16% | +$481K | 2.6% | 10 |
|
|
2023
Q3 | $5.87M | Sell |
3,915,000
-1,242,179
| -24% | -$1.86M | 5.39% | 6 |
|
|
2023
Q2 | $8.2M | Sell |
5,157,179
-1,910,000
| -27% | -$3.04M | 7.38% | 5 |
|
|
2023
Q1 | $5.07M | Hold |
7,067,179
| – | – | 4.38% | 7 |
|
|
2022
Q4 | $4.1M | Buy |
+7,067,179
| New | +$4.1M | 3.91% | 10 |
|